EN DE

Expleo Solutions Limited (EXPLEOSOL) Fair Value & Analysis

Technology · IN · Market cap ₹13.8B

ES Expleo Solutions Limited EXPLEOSOL · BSE
Price₹887.70
Fair Value₹2,213
Upside+149.3%
Quality72/100
Watch Expleo Solutions Limited for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Solidly profitable · 11.1% net margin
Low debt · generates free cash flow
Ranks above peers (13/14)
Moderate moat 61/100
Evidence: High Range ₹1,402 – ₹2,709 Share as image

Fair value as of: Aug 20, 2026

From 24 valuation models · updated today

Share price +23.1% over the past month.

A solid business, screening 149% undervalued on our models.

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • The rarer combination: high quality (72/100) AND below fair value. That earns a closer look rather than a quick verdict.
  • The price is below even our cautious bear case (₹1,402). The market is more pessimistic than our downside scenario.
  • A fairly wide model range (₹1,402 to ₹2,709) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

₹1,520 ₹437.73 Fair Value ₹2,213 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 20, 2026.

How to read this chart

60‑month range ₹437.73 – ₹1,520 · fair‑value band ₹1,402 – ₹2,709 · the ₹887.70 price screens below the ₹2,213 fair value. Dashed = 300-day average. As of Aug 20, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Expleo Solutions Limited (EXPLEOSOL) currently trades at ₹887.70, while our model-based Fair Value estimate is ₹2,213, implying the stock looks roughly 149.3% undervalued today. The Quality Score stands at 72/100 (solid quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Expleo Solutions Limited generated revenue of ₹11.1B at a net margin of 11.1%. Revenue grew 12.7% year over year. It earns a return on equity of 17.6%. The stock trades on a trailing P/E of 11.1. Fundamentals as of Aug 20, 2026

Our scenario range runs from ₹1,402 (bear case) to ₹2,709 (bull case); at ₹887.70, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 14% below its 52-week high and 57% above its 52-week low, currently above its 200-day average. For context, the median of 10 Technology peers we cover trades at 0% fair-value upside, at 149%, EXPLEOSOL screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF ₹1,328 ₹2,439 ₹4,505 80
Residual Income ₹530.03 ₹701.11 ₹2,165 76
Rev-Margin DCF ₹1,178 ₹2,048 ₹3,321 74
All 24 models by family
DCF Models
FCF DCF ₹1,374 ₹2,216 ₹4,524 38
Owner Earnings ₹1,696 ₹3,462 ₹7,073 31
5Y Revenue Exit ₹1,178 ₹2,006 ₹3,433 39
5Y EBITDA Exit ₹1,588 ₹2,909 ₹5,054 41
5Y P/E Exit ₹1,719 ₹3,349 ₹5,422 38
10Y Revenue Exit ₹1,200 ₹2,144 ₹3,430 36
10Y EBITDA Exit ₹1,519 ₹2,892 ₹5,351 37
10Y P/E Exit ₹1,610 ₹3,132 ₹5,699 35
Earnings-Based
Graham-Dodd ₹543.23 ₹3,606 ₹5,049 54
Lynch FV ₹1,053 ₹1,504 ₹1,956 50
PEG = 1.0 ₹1,053 ₹1,504 ₹1,956 46
EPV ₹992.65 ₹1,120 ₹1,232 59
Multiples
P/E Multiple ₹1,678 ₹2,237 ₹2,796 63
P/S Multiple ₹1,019 ₹1,358 ₹1,698 58
P/B Multiple ₹1,019 ₹1,358 ₹1,698 55
EV/EBIT ₹1,885 ₹2,437 ₹2,989 53
EV/EBITDA ₹1,717 ₹2,213 ₹2,709 54
EV/Revenue ₹1,066 ₹1,424 ₹1,783 43
Asset-Based
NCAV (Graham) ₹250.10 ₹335.14 ₹500.21 50
Growth DCF
Growth DCF ₹1,328 ₹2,439 ₹4,505 80
Rev-Margin DCF ₹1,178 ₹2,048 ₹3,321 74
Economic Profit
Residual Income ₹530.03 ₹701.11 ₹2,165 76
ROIC Compounder ₹1,158 ₹1,541 ₹2,061 72
Growth Earnings
Growth-Adj P/E ₹1,684 ₹2,405 ₹3,127 68

Widest divergence: DCF Models (₹2,892) versus Asset-Based (₹335.14). Highest evidence: Growth DCF (80).

Notify me when EXPLEOSOL reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) ₹11.1B
Revenue growth (YoY) +12.7%
Net margin 11.1%
Return on equity 17.6%
Free cash flow ₹1.2B FY2026
P/E ratio 11.1
More key figures
Operating margin 15.9%
EPS (TTM) ₹79.88
EPS growth (YoY) +73.2%

Figures from reported company fundamentals · as of Aug 20, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 72/100

Of which business quality 73 · Market factors (momentum, volatility) 51

Profitability 74
Margins and returns on capital today
Quality Growth 51
Are margins and returns improving?
Cashflow 57
Earnings quality: real cash, not paper profit
Fin. Strength 100
Balance sheet, leverage, solvency risk
Investment 64
Disciplined investing over empire-building
Low Volatility 73
Calm price path (market factor)
Momentum 41
Price trend over the last 3–12 months (market factor)
52W Momentum 45
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Expleo Solutions Limited, together with its subsidiaries, primarily provides software validation and verification services to the banking, financial services, and insurance industries worldwide.

Full company description

Expleo Solutions Limited, together with its subsidiaries, primarily provides software validation and verification services to the banking, financial services, and insurance industries worldwide. It offers computer programming, consultancy and related activities, quality management, software development, software testing, software development, digital transformation, product and process engineering, quality and testing, and customer support and maintenance services. The company was formerly known as SQS India BFSI Limited and changed its name to Expleo Solutions Limited in April 2019. Expleo Solutions Limited was incorporated in 1998 and is based in Chennai, India. Expleo Solutions Limited Limited is a subsidiary of Expleo Technology Germany GmbH.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Expleo Solutions Limited reported revenue of ₹11.1B in FY2026 versus ₹4.0B in FY2022, a compound +28.6%/yr. Reported net income was ₹1.2B in FY2026, compounding +23.1%/yr from FY2022.

Growth Quality 100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2026)
₹11.1B
Latest YoY
+8.1%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+7.0%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+29.8%
Avg. growth/yr (6Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+26.6%
Revenue +28.6%/yr
FY22 ₹4.0B
FY23 ₹9.0B
FY24 ₹9.6B
FY25 ₹10.2B
FY26 ₹11.1B
Net income +23.1%/yr
FY22 ₹539M
FY23 ₹1.3B
FY24 ₹904M
FY25 ₹1.0B
FY26 ₹1.2B

Watch EXPLEOSOL: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Expleo Solutions Limited Fair Value". https://www.fairvalue-calculator.com/stock/EXPLEOSOL

Peer Group

Information Technology Services · 491 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 72 · Top 25%
Fair Value upside +149% · Top 25%
Return on equity (TTM) 18% · Top 25%
Return on assets 11% · Top 25%
Net margin (TTM) 11% · Top 25%
Operating margin (TTM) 16% · Top 25%
Revenue growth 13% · Above median
Dividend yield (TTM) 5.6% · Top 25%

Valuation Multiples vs Information Technology Services median · lower = cheaper

P/E (TTM) 11.1× · Cheaper than 75% of peers
P/B 1.77× · Cheaper than median
P/S (TTM) 1.24× · Pricier than median
P/FCF 0.1× · Cheaper than 75% of peers
EV/EBITDA 6.1× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE100 · sector 34
FUTURE64 · sector 27
PAST70 · sector 35
HEALTH100 · sector 97
DIVIDEND100 · sector 35

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Information Technology Services stocks, each showing price versus our Fair Value estimate (as of Aug 20, 2026).

Stock Price Fair Value vs Fair Value
International Business Machines Corporation IBM $235.98 $175.76 -26%
Tata Consultancy Services Limited TCS ₹2,350 ₹3,473 +48%
Infosys Limited INFY ₹1,115 ₹2,006 +80%
HCL Technologies Limited HCLTECH ₹1,365 ₹1,722 +26%
Wipro Limited WIPRO ₹183.94 ₹314.26 +71%
Tech Mahindra Limited TECHM ₹1,625 ₹1,521 -6%
Samsung SDS Co 018260 235,500 KRW 235,321 KRW -0%
Coforge Limited COFORGE ₹1,815 ₹983.97 -46%
Persistent Systems Limited PERSISTENT ₹5,474 ₹3,259 -40%
Hyundai Autoever Corporation 307950 433,000 KRW 186,323 KRW -57%

Compare Expleo Solutions Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Expleo Solutions Limited (EXPLEOSOL) overvalued or undervalued?
As of Aug 20, 2026, our model estimates a fair value of ₹2,213 versus a price of ₹887.70, about +149% (undervalued).
What is the fair value of EXPLEOSOL?
Our model-based fair value for Expleo Solutions Limited is ₹2,213 (as of Aug 20, 2026), built from audited fundamentals. The current price: ₹887.70.
What is the quality score of EXPLEOSOL?
Expleo Solutions Limited has a Quality Score of 72/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Expleo Solutions Limited (EXPLEOSOL)?
Expleo Solutions Limited reported trailing-twelve-month revenue of about ₹11.1B (latest available figure, as of Aug 20, 2026).
What is the net profit margin of EXPLEOSOL?
The net profit margin of Expleo Solutions Limited is about 11.1%, meaning it keeps roughly 11.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Expleo Solutions Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.